DeepHealth, a Somerville, Massachusetts-based subsidiary of RadNet, has received FDA 510(k) clearance for TechLive, a system that enables centralized, remote operation of MR, CT, PET/CT and ultrasound procedures.

The vendor-agnostic platform allows technologists to scan patients at multiple sites from a single location, a capability aimed at easing staffing shortages in radiology. According to RadNet, more than 300 imaging systems in its network are already connected through TechLive.

A pilot program at 64 RadNet facilities in the New York area during the second quarter of 2025 showed a 42% reduction in MR room closure hours compared with the same period in 2024. The company attributed the improvement to the ability to direct experienced staff to where they were needed in real time.
The ultrasound component of the platform enables senior sonographers and physicians to guide on-site technologists through complex cases remotely, a process that requires real-time operator expertise.

“TechLive represents a paradigm shift in how we approach imaging operations,” said Sham Sokka, Ph.D., chief operating and technology officer at DeepHealth. “By enabling real-time remote expertise, we are not only addressing today’s staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities.”

DeepHealth operates within RadNet’s digital health segment, which develops AI-enabled health informatics tools for radiology. RadNet, based in Los Angeles, runs 401 outpatient imaging centers in eight U.S. states and employs more than 11,000 people, including contracted radiologists.

U.S. Healthcare Homepage